S. Eckhardt
Impact in
-
- Cancer Treatment and Pharmacology
- Global Cancer Incidence and Screening
-
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diabetes Management and Research
Papers in
-
- Lung Cancer Treatments and Mutations 3
-
- Cancer therapeutics and mechanisms 4
- Co-authors
- G.P. Murphy (2 shared papers)F Badellino (2 shared papers)S. Kerpel‐Fronius (14 shared papers)A Aynsley‐Green (1 shared paper)Mark J. Dunne (1 shared paper)MT Dattani (1 shared paper)Keith Lindley (1 shared paper)Cheikhou Kane (1 shared paper)
- Journals
- Cancer Chemotherapy and Pharmacology (5 papers)Cancer (2 papers)Journal of Toxicology and Environmental Health (2 papers)Oncology (2 papers)Journal of Inherited Metabolic Disease (1 paper)
- Partner nations
- HungaryUnited KingdomUnited States
In The Last Decade
S. Eckhardt
42 papers receiving 375 citations
Peers
Comparison fields: 5 of 78
- Oncology 134
- Endocrinology, Diabetes and Metabolism 78
- Clinical Biochemistry 26
- Cancer Research 54
- Genetics 28
Countries citing papers authored by S. Eckhardt
This map shows the geographic impact of S. Eckhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Eckhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Eckhardt more than expected).
Fields of papers citing papers by S. Eckhardt
This network shows the impact of papers produced by S. Eckhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Eckhardt. The network helps show where S. Eckhardt may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Eckhardt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 72 | |
| 2 | 1994 | 44 | |
| 3 | 1994 | 32 | |
| 4 | 2000 | 22 | |
| 5 | 2008 | 18 | |
| 6 | 1979 | 15 | |
| 7 | 1994 | 13 | |
| 8 | Uptake of labeled dianhydrogalactitol into human gliomas and nervous tissue. | 1977 | 13 |
| 9 | 1990 | 13 | |
| 10 | 1987 | 13 | |
| 11 | 1973 | 12 | |
| 12 | 1982 | 11 | |
| 13 | 1993 | 10 | |
| 14 | 1979 | 8 | |
| 15 | 1983 | 8 | |
| 16 | 2017 | 7 | |
| 17 | 1990 | 7 | |
| 18 | Phase II study of 4'-epi-doxorubicin in patients with untreated, extensive small cell lung cancer. South-East European Oncology Group (SEEOG). | 1990 | 7 |
| 19 | 1988 | 6 | |
| 20 | 1974 | 6 |
About S. Eckhardt
S. Eckhardt is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Surgery and Biochemistry, having authored 44 papers that have together received 397 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (4 papers), Cancer Treatment and Pharmacology (3 papers), Glioma Diagnosis and Treatment (3 papers), Peptidase Inhibition and Analysis (3 papers), Lung Cancer Research Studies (3 papers), Amino Acid Enzymes and Metabolism (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Oncology (134 citations), Endocrinology, Diabetes and Metabolism (78 citations), Clinical Biochemistry (26 citations), Cancer Research (54 citations) and Genetics (28 citations). S. Eckhardt has collaborated with scholars based in Hungary, United Kingdom and United States. Frequent co-authors include G.P. Murphy, F Badellino, S. Kerpel‐Fronius, A Aynsley‐Green, Mark J. Dunne, MT Dattani, Keith Lindley, Cheikhou Kane, Peter J. Milla and Paul Johnson. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Cancer, Journal of Toxicology and Environmental Health, Oncology and Journal of Inherited Metabolic Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.